Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis

Clinical and Experimental Immunology

Volumn 136, Issue 3, 2004, Pages 513-520

  Yamamoto, M ^a   Matsuyama, W ^a,c   Oonakahara, K ^a   Watanabe, M ^a   Higashimoto, I ^a   Kawabata, M ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Minami Kyushu Hospital   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

ATL; HTLV I associated bronchopneumonopathy; IP 10; MIP 1 ; TGF

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ADULT; AGED; ARTICLE; BRONCHIOLITIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; T CELL LEUKEMIA; T LYMPHOCYTE ACTIVATION; VIRUS CARCINOGENESIS; VIRUS INFECTION;

ADULT; AGED; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-8; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; PREVALENCE; PYRIMIDINONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA;

EID: 2542526097     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02485.x     Document Type: Article

References (43)

1. Homma H, Yamanaka A, Tanimoto S et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 1983; 83:63-9.
2. Sato A, Chida K, Iwata M, Hayakawa H. Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1992; 146:473-8.
3. Kawakami K, Kadota J, Iida K et al. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells. Clin Exp Immunol 1997; 107:410-6.
4. + cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med 1995; 152:613-8.
5. Blayney DW, Blattner WA, Jaffe ES, Gallo RC. Retroviruses in human leukemia. Hematol Oncol 1983; 1:193-204.
6. Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 2003; 17:26-38.
7. Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1:1031-2.
8. Nakao K, Ohba N, Matsumoto M. Noninfectious anterior uveitis in patients infected with human T lymphotropic virus type I. Jpn J Ophthalmol 1989; 33:472-81.
9. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989; 1:441.
10. Tamura K, Yokota T, Mashita R, Tamura S. Pulmonary manifestations in adult T cell leukemia at the time of diagnosis. Respiration 1993; 60:115-9.
11. Yoshioka R, Yamaguchi K, Yoshinaga T, Takatsuki K. Pulmonary complications in patients with adult T cell leukemia. Cancer 1985; 55:2491-4.
12. Maruyama I, Thihara J, Sakashita R et al. HTLV-I associated bronchopneumonopathy - a new clinical entity? Am Rev Respir Dis 1988; 137:46.
13. Sugimoto M, Nakashima H, Watanabe S et al. T lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987; 2:1220.
14. Sugimoto M, Nakashima H, Kawano O, Ando M, Araki S. Bronchoalveolar T lymphocytosis in HTLV-1-associated myelopathy. Chest 1989; 95:708.
15. Sugimoto M, Nakashima H, Matsumoto M, Uyama E, Ando M, Araki S. Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid. Am Rev Respir Dis 1989; 139:1329-35.
16. Sugimoto M, Mita S, Tokunaga M et al. Pulmonary involvement in human T cell lymphotropic virus type-I uveitis: T lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur Respir J 1993; 6:938-43.
17. Seki M, Higashiyama Y, Kadota J et al. Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T cell lymphotropic virus type 1. Chest 2000; 118:1754-61.
18. Tateishi U, Nishihara H, Miyasaka K. HTLV-1-associated bronchopneumonopathy (HAB): CT pathological correlation. Clin Radiol 2001; 56:664-6.
19. Higashiyama Y, Katamine S, Kohno S et al. Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol 1994; 96:193-201.
20. Seki M, Higashiyama Y, Mizokami A et al. Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax/rex mRNA in infected lung tissues. Clin Exp Immunol 2000; 120:488-98.
21. Miyazato A, Kawakami K, Iwakura Y, Saito A. Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T lymphotropic virus type 1. Clin Exp Immunol 2000; 120:113-24.
22. Matsuyama W, Kawabata M, Mizoguchi A, Iwami F, Wakimoto J, Osame M. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity. Clin Exp Immunol 2003; 133:397-403.
23. Matsuzaki T, Nakagawa M, Osame M. Human T lymphotrophic virus type-I (HTLV-I) seroprevalence in Kagoshima Prefecture. Med J Kagoshima Univ 1993; 45:135-41.
24. Miyoshi I, Kubonishi I, Yoshimoto S et al. Type C virus particles in a cord T cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981; 294:770-1.
25. Matsuyama W, Mizoguchi A, Iwami F et al. Clinical investigation of pulmonary Mycobacterium avium complex infection in human T lymphotrophic virus type I carriers. Thorax 2000; 55:388-92.
26. Xu LL, McVicar DW, Ben Baruch A et al. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol 1995; 25:2612-7.
27. Kinoshita T, Shimoyama M, Tobinai K et al. Detection of mRNA for the tax1/rex1 gene of human T cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86:5620-4.
28. Xu X, Heidenreich O, Kitajima I et al. Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene 1996; 13:135-42.
29. Arnulf B, Villemain A, Nicot C et al. Human T cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood 2002; 100:4129-38.
30. Matsuyama W, Kubota R, Hamasaki T et al. Enhanced inhibition of lymphocyte activation by Mycobacterium avium complex in human T lymphotrophic virus type I carriers. Thorax 2001; 56:394-7.
31. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation. I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996; 156:2095-103.
32. Cook DN, Beck MA, Coffman TM et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995; 269:1583-5.
33. Kadota J, Mukae H, Tomono K, Kohno S. High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis. Chest 2001; 120:602-7.
34. Ward SG, Westwick J. Chemokines: understanding their role in T lymphocyte biology. Biochem J 1998; 333:457-70.
35. Gattass CR, King LB, Luster AD, Ashwell JD. Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes. J Exp Med 1994; 179:1373-8.
36. Hanon E, Stinchcombe JC, Saito M et al. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000; 13:657-64.
37. Katoh S, Matsubara Y, Taniguchi H et al. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis. Clin Exp Immunol 2001; 126:545-50.
38. Takahashi T, Suga M, Matsukawa A et al. Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1. Eur Respir J 2001; 17:360-7.
39. Rollins BJ. Chemokines. Blood 1997; 90:909-28.
40. Takizawa H, Desaki M, Ohtoshi T et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 1997; 156:266-71.
41. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Kara K. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 1996; 63:42-8.
42. Yasunaga J, Matsuoka M. Leukemogenesis of adult T cell leukemia. Int J Hematol 2003; 78:312-20.
43. Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T cell leukemia in Japan. Int J Hematol 2002; 76 (Suppl. 2):240-5.